Re: “Clinical Recommendations for High Altitude Exposure of Individuals with Pre-Existing Cardiovascular Conditions: A Joint Statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine” by Parati et al.

Author(s):  
Theocharis Koufakis ◽  
Omar G. Mustafa ◽  
Pantelis Zebekakis ◽  
Kalliopi Kotsa
2018 ◽  
Vol 39 (17) ◽  
pp. 1546-1554 ◽  
Author(s):  
Gianfranco Parati ◽  
Piergiuseppe Agostoni ◽  
Buddha Basnyat ◽  
Grzegorz Bilo ◽  
Hermann Brugger ◽  
...  

2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.


Sign in / Sign up

Export Citation Format

Share Document